These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25425988)

  • 21. [Cytomegalovirus cholestasis in an immunocompetent host].
    Ouandaf A; Chergui H; Seffar M; Chocho Z; Marcil S; Ouazzani H; Kabbaj H
    Ann Biol Clin (Paris); 2019 Jun; 77(3):323-326. PubMed ID: 30977729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus ulcer. Successful treatment with valganciclovir.
    Lambert EM; Strasswimmer J; Lazova R; Antaya RJ
    Arch Dermatol; 2004 Oct; 140(10):1199-201. PubMed ID: 15492181
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl.
    Burri M; Wiltshire H; Kahlert C; Wouters G; Rudin C
    Pediatr Infect Dis J; 2004 Mar; 23(3):263-6. PubMed ID: 15014306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of cytomegalovirus pneumonia with ganciclovir in an immunocompetent infant].
    Siret D; David V
    Arch Pediatr; 2002 May; 9(5):499-502. PubMed ID: 12053544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral valganciclovir for CMV gastritis.
    Saouli AC; Salvade I; Saldarriaga J; Manuel O; Venetz JP; Golshayan D; Sempoux C; Pascual M
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):e50-1. PubMed ID: 27067039
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.
    Mattes FM; Hainsworth EG; Hassan-Walker AF; Burroughs AK; Sweny P; Griffiths PD; Emery VC
    J Infect Dis; 2005 Jan; 191(1):89-92. PubMed ID: 15593008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.
    Witzke O; Hauser IA; Bartels M; Wolf G; Wolters H; Nitschke M;
    Transplantation; 2012 Jan; 93(1):61-8. PubMed ID: 22094954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
    Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
    Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated cytomegalovirus infection in an immunocompetent adult successfully treated with ganciclovir.
    López-Contreras J; Ris J; Domingo P; Puig M; Rabella N; Nolla J
    Scand J Infect Dis; 1995; 27(5):523-5. PubMed ID: 8588148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
    Montesinos P; Sanz J; Cantero S; Lorenzo I; Martín G; Saavedra S; Palau J; Romero M; Montava A; Senent L; Martínez J; Jarque I; Salavert M; Córdoba J; Gómez L; Weiss S; Moscardó F; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):730-40. PubMed ID: 19450758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.
    Snydman DR
    Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiogenic shock due to cytomegalovirus myocarditis: successful clinical treatment.
    Baumgratz JF; Vila JH; Silva JP; Fonseca Ld; Rodrigues EA; Knobel E
    Rev Bras Cir Cardiovasc; 2010; 25(2):149-53. PubMed ID: 20802904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Valganciclovir maintenance therapy in AIDS: treatment failure due to the development of cytomegalovirus resistance to ganciclovir].
    Couzigou C; Mazeron MC; Escaut L; Merad M; Vittecoq D
    Med Mal Infect; 2005 Feb; 35(2):98-100. PubMed ID: 15780901
    [No Abstract]   [Full Text] [Related]  

  • 34. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
    N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report.
    Carpani G; Foresti S; Dell'Oro R; Grassi G; Bombelli M
    BMC Infect Dis; 2019 Jan; 19(1):34. PubMed ID: 30626344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients.
    Oppenheimer F; Gonzalez-Molina M; Rubio M
    Clin Transplant; 2007; 21(4):441-8. PubMed ID: 17645702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients.
    van Boxtel LA; van der Lelij A; van der Meer J; Los LI
    Ophthalmology; 2007 Jul; 114(7):1358-62. PubMed ID: 17296229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus colitis in an immunocompetent old woman successfully treated with ganciclovir: a case report.
    Tsai HL; Huang CK; Cho G; Chen GH; Yang MD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):289-92. PubMed ID: 8705882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir.
    Miguelez M; Gonzalez A; Perez F
    Scand J Infect Dis; 1998; 30(3):304-5. PubMed ID: 9790142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.